Document is current
Any future updates will be listed below
-
Authors
Galli, Lukas
Bernhard, Johannes
Undt, Iris E.
Haider, Patrick
Hengstenberg, Christian
Krychtiuk, Konstantin A. https://orcid.org/0000-0001-7792-2837
Speidl, Walter S.
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 25 November 2025
Accepted: 13 March 2026
First Online: 30 March 2026
Declarations
: KAK: Speaker fees: Amarin, Daiichi Sankyo, Zoll Medical; Consulting Fees: Amarin, Novartis, Sanofi; Travel Support: Amgen, Sanofi, Daiichi Sankyo; LG: Consulting Fees: Amgen; WS: Speaker fees: Amarin, Amgen, Daiichi Sankyo, Sanofi; Consulting Fees: Amarin, Amgen, Novartis, Sanofi; Travel Support: Amgen; JB: Travel Support: Daiichi Sankyo.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of the Medical University of Vienna. Ethics code: 1207/2025.
: No AI or AI-assisted technologies have been used.
